Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, double-blind, randomized, Phase 2b trial to evaluate the efficacy of
atacicept in subjects with systemic lupus erythematosus (SLE).